BBVA
FOLD

Banco Bilbao Vizcaya Argentaria’s Amicus Therapeutics FOLD Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-60,000
Closed -$904K – 712
2020
Q2 		$904K Buy
60,000
+25,000
+71% +$305K 0.03% 424
2020
Q1 		$323K Buy
35,000
+10,000
+40% +$95.1K 0.01% 563
2019
Q4 		$243K Buy
+25,000
New +$229K 0.01% 645

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's FOLD Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Amicus Therapeutics (FOLD) in Q3 2020, closing a stake of 60,000 shares — an estimated $904K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in FOLD in Q4 2019 and held it in 3 quarters. The position peaked at $904K in Q2 2020. 251 funds tracked by Wall St. Rank hold FOLD as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Amicus Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 60,000 Amicus Therapeutics shares in Q3 2020, an estimated $904K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Amicus Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Amicus Therapeutics position peaked at $904K in Q2 2020.
  • 251 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.